Academia
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and biopharmaceutical industry.
The mechanisms that cause this collapse of normal tissue function is not well understood, but researchers recently identified key mechanisms behind it.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-lead research team believes a new approach that inhibits a specific fatty acid binding protein may be the key to halting disease progression.
It was another busy week for clinical trial updates. Here’s a look.
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.
The research was published in the journal Cancer Discovery.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The study notes that about half of recent drug approvals were built on a single pivotal clinical trial. Typically, two pivotal, Phase III trials were the norm.
They dub it a type of Trojan Horse and believe it has the potential to treat atherosclerosis, a top cause of death in the U.S.
Peter Jones, a professor of pharmacology at the University of Nevada in Reno, has been researching the disease for years and may have helped to unlock one of the first treatments for the disease.
PRESS RELEASES